28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

518<br />

Efficacy-Field Evidence<br />

in the population of the four experimental and<br />

neighboring regions was investigated and repeated<br />

investigations on the spread of wild<br />

polioviruses (and other enteroviruses) were conducted<br />

in several Czech and Slovak regions. The<br />

main attention was paid to relations between<br />

the amount of detected strains and the poliomyelitis<br />

morbidity*. The results, obtained before<br />

the usual onset and at the peak of the usual<br />

polio season (June-September), are of particular<br />

importance. From the results, discussed in<br />

greater detail elsewhere (Burian, Vojtová and<br />

others), I should like to demonstrate the following<br />

main facts shown on two maps (Figures 5<br />

and 6):<br />

(a) Repeated investigations in four regions,<br />

where in the winter of 1958-1959 the live vaccine<br />

was administered (Fig. 5), revealed that attenuated<br />

viruses disappear relatively rapidly from<br />

the population. Isolated viruses, if detected<br />

later in non-vaccinated individuals (white circles<br />

on the map), were most probably wild viruses<br />

imported to these regions from elsewhere, or<br />

wild viruses occurring in the non-vaccinated<br />

part of the population. (It must be emphasized<br />

that the first field trial with the live vaccine was<br />

conducted in a relatively small part of the population-in<br />

less than 50 per cent of children aged<br />

two to eight years). The polio-morbidity in<br />

these four regions (black squares on the map;<br />

one square stands for one case of poliomyelitis)<br />

does not have any peculiar features.<br />

(b) Very important results are shown on the<br />

map summarizing the results of two investigations<br />

of the poliovirus spread in Czechoslovakia<br />

in 1959 during June (A) and September (B),<br />

and which gives also the number of cases of<br />

poliomyelitis in the second half of 1959 (Fig.<br />

6). The results indicate that in regions neighboring<br />

upon those where the live vaccine was<br />

administered, the incidence of polioviruses was<br />

low and that thus, most probably, these viruses<br />

did not penetrate into neighboring regions. (It<br />

must also be taken into account that the vaccination<br />

was carried out in winter). If later there<br />

was a higher incidence of viruses in some localities<br />

(such as in the Gottwaldov region), this<br />

* Specimens of feces, proportional to the population<br />

densitv, were collected by random sampling,<br />

predominantly from children. In child communities,<br />

never more than two specimens were taken from one<br />

community.<br />

was more probably due to the penetration of<br />

wild viruses from neighboring Slovak regions,<br />

particularly the Zilina region, which is very<br />

close to the Gottwaldov region. (It is interesting<br />

to note that in 1959 there was an extensive<br />

poliomyelitis epidemic in neighboring Hungary,<br />

which borders on Slovakia along the entire<br />

frontier.)<br />

The most important conclusion from these<br />

investigations is that, when there was a higher<br />

incidence of polioviruses in the population,<br />

which had been practically evenly vaccinated<br />

with the inactivated vaccine, there was also a<br />

higher incidence of poliomyelitis. In other<br />

words, we may say that not even the previous<br />

high vaccination rate with inactivated vaccine<br />

was able to prevent the spread of polioviruses<br />

and that to a certain degree, we have to rely on<br />

chance whether an unexpected spread of viruses<br />

will occur or not. If we add to this the defects<br />

of seroimmunity, it is evident why in 1959 there<br />

was a substantially higher morbidity in Slovakia,<br />

as shown in Fig. 2 and why we considered<br />

the future epidemiological prognosis of poliomyelitis<br />

in our country uncertain.*<br />

The main purpose of my report was to give an<br />

idea of the trend of our deliberations and to<br />

demonstrate at least some fundamental facts<br />

on which we based our decision to use the live<br />

vaccine for mass vaccination. I think that our<br />

results indicated clearly the necessity to improve<br />

the state of immunity of our most susceptible<br />

population. A comparison of the results of the<br />

first field trial with the live vaccine with those<br />

after the administration of a fourth dose of<br />

inactivated vaccine on a mass scale, however,<br />

revealed also the method of how to achieve<br />

this improvement most expediently. I have tried<br />

to summarize the balance of our deliberations<br />

on the advantages of either method in Table 6.<br />

The objection could certainly be raised that<br />

our decision was premature. I dare not, however,<br />

answer the second aspect of this objection,<br />

and I doubt that anybody will be able to do so.<br />

It is my opinion that it would be much more<br />

difficult to explain to our people in the case<br />

of an epidemic, why we did not undertake every-<br />

* The results assembled during the first few months<br />

of 1960 confirmed to a certain extent that these fears<br />

were justified. The number of patients between<br />

1 January 1960 and 28 March 1960 was, as comPared<br />

with the same period in 1959, three times greater<br />

(66:22), and several small local epidemics occurred.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!